title: Xe-CT in cerebrovascular disease and moyamoya disease.
abstract: (1) Negative response to acetazolamide challenge test using Xe-CT is a reliable indicator for identifying the hemodynamic compromise. (2) The hemodynamic compromise may be a cause of TIAs in some patients with chronic cerebrovascular occlusive diseases. (3) The brain suffering from hemodynamic compromise actively works to induce collateral blood channels.
authors.affiliation: Department of Neurosurgery, Showa University Fujigaoka Hospital, Japan.
authors.forename: R
authors.initials: R
authors.lastname: Suzuki
authors.forename: T
authors.initials: T
authors.lastname: Nariai
authors.forename: Y
authors.initials: Y
authors.lastname: Matsushima
authors.forename: K
authors.initials: K
authors.lastname: Hirakawa
mesh_terms: D000086:Acetazolamide; D001921:Brain / Q000098:blood supply*; D002545:Brain Ischemia / Q000000981:diagnostic imaging*; D002245:Carbon Dioxide; D006439:Hemodynamics / Q000502:physiology; D006801:Humans; D002546:Ischemic Attack, Transient / Q000000981:diagnostic imaging* / Q000601:surgery; D009072:Moyamoya Disease / Q000000981:diagnostic imaging* / Q000601:surgery; D012016:Reference Values; D012039:Regional Blood Flow / Q000502:physiology; D015899:Tomography, Emission-Computed, Single-Photon; D014980:Xenon Radioisotopes
chemical_list: D014980:Xenon Radioisotopes; D002245:Carbon Dioxide; D000086:Acetazolamide